Answers are grounded in this paper and cite their sources.
Three-dimensional (3D) bioprinting is a transformative technology for engineering tissues for disease modeling and drug screening and building tissues and organs for repair, regeneration, and replacement. In this Viewpoint, we discuss technological advances in 3D bioprinting, key remaining challenges, and essential milestones toward clinical translation. Description This Viewpoint discusses current opportunities and challenges in the 3D bioprinting of tissues and organs as it advances toward clinical translation.
No takes yet. Share an insight, caveat, or question.
Bliley et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: